A Novel Approach to Overseeing the Clinical Application of Generative AI

This Viewpoint discusses current regulatory frameworks governing the use of generative artificial intelligence (AI) in health care and proposes an alternative oversight system.

Corresponding Author: David Blumenthal, MD, MPP, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115 (dblumenthal@hsph.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.